Think about it? Had Amarin published a PR about Vascepa and it’s efficacy, it would only benefit the Generics. Until they settle the lawsuit (infringement) and or EPADI (mariachi & co.) is successful, then there’s no sense to publish the facts. Our system will only deride Amarin and Vascepa with false reports.